CASRAI Dictionary

Tag: uk research integrity office

  • Research Integrity Jobs: Roles, Salaries and How to Start

    Research integrity jobs span universities, funders, publishers and independent charities, and the core role — Research Integrity Officer (RIO) — is the named individual responsible for advising on ethical conduct, investigating misconduct allegations, and protecting the reliability of published research. In the UK, advertised RIO salaries typically range from around £31,000 at entry level to over £70,000 for senior publisher-side leads, with most institutional roles clustering between £35,000 and £50,000.

    A research integrity officer is the institutional point of contact who receives, assesses and — where warranted — investigates concerns about research misconduct, while also delivering training and policy guidance to protect the integrity of an organisation’s research output. This article maps the job titles, qualifications, salary bands and entry routes that make up this career path — not a general definition of what research integrity means.

    What Is a Research Integrity Officer?

    A Research Integrity Officer investigates allegations of research misconduct, advises researchers on ethical conduct, and reports outcomes to the relevant oversight body. The role exists in some form at nearly every UK university and at a growing number of publishers and funders, though the legal weight behind it differs sharply by jurisdiction.

    In the United States, the position is a compliance requirement: any institution receiving Public Health Service funding must designate a RIO who liaises directly with the federal Office of Research Integrity (ORI), a division of the US Department of Health and Human Services, and follows the process set out in the ORI’s Handbook for Institutional Research Integrity Officers. In the UK, there is no single statutory equivalent — instead, universities appoint their own RIOs under internal codes of practice, informed by the sector-wide Concordat to Support Research Integrity, and can draw on independent advice from the UK Research Integrity Office (UKRIO), a charity that has offered confidential guidance on research conduct since 2006. Across the European Union, national RIOs coordinate through the European Network of Research Integrity Offices (ENRIO), which shares practice guidance rather than enforcing a single legal standard.

    Day to day, the job blends investigation, education and policy work: reviewing complaints, running training sessions on responsible conduct, updating institutional policy, and — increasingly — adjudicating authorship disputes. Some of those disputes now turn on contributor-role statements built on the CRediT taxonomy, which CASRAI originated in 2014 and which is now stewarded by NISO as ANSI/NISO Z39.104-2022; RIOs handling authorship complaints benefit from fluency in how those roles are defined and applied, alongside broader authorship criteria.

    What Job Titles and Employers Are Hiring?

    “Research integrity officer” is only one of several job titles covering this work — recruiters use the term inconsistently, so a job search needs to cast a wider net. Current UK vacancies (mid-2026) show the following pattern of employer types and titles:

    • Universities — Research Integrity Manager, Research Integrity and Governance Officer, Research Policy Manager (e.g. a dual Research Policy Manager recruitment at the University of Bath’s Research Policy, Governance and Integrity team, advertised May 2026), and combined roles such as Research, Ethics, Governance and Integrity Manager.
    • Academic publishers — Research Integrity Manager, Research Integrity & Publishing Ethics Lead, and Head of Journal Audits & Research Integrity, reflecting the post-publication misconduct-detection work publishers now run at scale.
    • Independent bodies and charities — UKRIO itself periodically recruits a Research Integrity Manager to support its advisory casework across the UK sector.
    • Funders and government-adjacent bodies — research governance and compliance officer roles that sit alongside, rather than inside, a formal RIO title.

    Search volume data confirms the fragmentation: “research integrity jobs” and “research ethics jobs” each attract broadly comparable UK search interest, while the narrower “research integrity officer” phrase is searched far less often — evidence that most candidates search by sector or employer rather than by exact job title.

    What Qualifications Do You Need?

    There is no single licence or certification that gates entry to research integrity work, but employers converge on a consistent set of requirements across advertised UK vacancies.

    Requirement Typical expectation
    Academic background Degree in a relevant discipline; a Master’s or PhD is commonly required or strongly preferred for senior and university-based roles
    Sector knowledge Working understanding of UK research governance, the Concordat to Support Research Integrity, and relevant ethics-approval processes
    Investigative skill Ability to assess evidence dispassionately, conduct interviews, and write defensible investigation reports
    Communication Confident delivery of training and policy guidance to researchers, committees and senior leadership
    Prior experience Background in research administration, ethics committee work, publishing editorial roles, or active research is commonly favoured over integrity work with no research-sector grounding

    Specialist short courses and CPD in research ethics and integrity — offered by UKRIO, professional bodies and university research-development units — strengthen an application but are not, in most UK institutions, a formal precondition for the role.

    What Salary Can You Expect in the UK?

    Advertised UK salaries for research integrity roles vary considerably by employer type and seniority. The following reflects a representative sample of live and recent 2026 postings:

    Role Employer type Advertised salary (GBP)
    Research Integrity Officer Major research institute £40,500 – £46,000
    Research Integrity Officer Russell Group university £31,406 – £38,587
    Research Integrity Associate Academic publisher £30,000 – £42,000
    Head of Research Operations (integrity remit) Senior institutional leadership £58,225 – £87,974
    Research Integrity Editor Academic publisher, senior track £72,069

    The pattern is clear: entry and mid-level institutional roles sit in the low-to-mid £30,000s–£40,000s, publisher-side and senior leadership roles climb toward £60,000–£80,000+, and progression typically comes from moving between institutional, publisher and senior-governance tracks rather than promotion within a single fixed ladder.

    How Do You Get Started?

    Most people arrive at research integrity work sideways, from research administration, ethics-committee support, editorial roles or an active research career, rather than through a dedicated entry-level pipeline. A practical route in looks like this:

    1. Build a base in research administration, ethics review, or editorial/publishing work — this is where most current RIOs started.
    2. Get close to your institution’s or publisher’s governance processes: volunteer for an ethics committee, a research integrity champion scheme, or misconduct-policy review.
    3. Take structured CPD in research ethics and integrity, such as courses referenced by UKRIO or sector bodies, to formalise sector-specific knowledge.
    4. Apply laterally for titles beyond “Research Integrity Officer” — Research Governance Officer, Research Policy Manager and Publishing Ethics Lead all lead to the same career track.
    5. For publisher-side roles, build familiarity with post-publication tools (plagiarism detection, image-integrity screening, retraction workflows) alongside ethics knowledge.

    Frequently Asked Questions

    What does a research integrity officer do?

    A research integrity officer receives and assesses allegations of research misconduct, leads or oversees investigations, advises researchers on ethical conduct and governance, and delivers institutional training. In regulated US contexts, they also serve as the formal liaison to the federal Office of Research Integrity.

    What is the UK Research Integrity Office?

    The UK Research Integrity Office (UKRIO) is an independent charity, not a government regulator, that provides confidential, impartial advice to researchers and institutions on good practice and allegations of misconduct. It periodically recruits Research Integrity Manager roles itself and publishes sector guidance, including its Code of Practice for Research.

    Is a research integrity job stressful?

    Research integrity roles can be demanding: officers routinely handle confidential misconduct allegations, mediate disputes between researchers, and balance institutional reputation against fair process. Case volume and emotional weight vary by employer, but the role’s investigative and mediating functions make sustained pressure a realistic expectation rather than an edge case.

    What This Means for the Profession

    Demand signals point toward continued, if modest, growth: search interest in “research integrity jobs” rose across UK queries through late 2025 and into 2026, and publishers are visibly expanding dedicated integrity and publishing-ethics teams rather than folding the work into general editorial roles. For institutions, this points to research integrity maturing from an ad hoc committee duty into a recognised, resourced career track — one that increasingly requires fluency in contributor-role and authorship frameworks alongside classical misconduct investigation. For prospective candidates, the practical implication is to search broadly across job titles and employer types rather than waiting for postings titled exactly “Research Integrity Officer.”

  • Who Handles Research Misconduct in 4 Countries?

    Who handles research misconduct depends entirely on the jurisdiction: no single global regulator exists. The United States channels federally funded cases through the Office of Research Integrity (ORI) under 42 CFR Part 93; the UK relies on individual universities advised by the UK Research Integrity Office (UKRIO); Australia splits oversight between the NHMRC/ARC-run Australian Research Integrity Committee (ARIC) and institutions applying the Australian Code for the Responsible Conduct of Research; and Canada’s Tri-Agency Secretariat on Responsible Conduct of Research (SRCR) enforces the Tri-Agency Framework across CIHR, NSERC and SSHRC-funded work. In all four systems, the employing institution — not the national body — conducts the actual investigation.

    Research misconduct is fabrication, falsification, or plagiarism in proposing, performing, reviewing, or reporting research — a definition first codified in US federal regulation and echoed, with local variation, across the other three systems discussed below.

    Contents

    Who actually investigates research misconduct?

    In every major research system, the first-line investigator is the researcher’s own institution, not a national regulator. National bodies — ORI, UKRIO, ARIC, and Canada’s SRCR — exist to set standards, provide oversight, and in some cases review procedural fairness, but they rarely re-investigate the underlying facts themselves.

    This “institution-first” model is near-universal because misconduct findings usually require discipline-specific expertise, access to lab notebooks, data, and witnesses that only the host institution can readily obtain. National oversight bodies then step in at different points: before a case (setting definitions and required procedures), during it (advising or auditing), or after it (reviewing the outcome or deciding on federal funding consequences).

    United States: the Office of Research Integrity (ORI)

    The Office of Research Integrity (ORI), part of the US Department of Health and Human Services, oversees misconduct involving research funded by the Public Health Service, including the National Institutes of Health (NIH). ORI does not typically conduct the initial fact-finding itself.

    • Institutions receiving PHS funding must maintain written misconduct policies compliant with 42 CFR Part 93, the federal research misconduct regulation.
    • Institutions run the inquiry and investigation; ORI oversees the process, can require corrective action, and can impose federal funding debarment.
    • The National Science Foundation (NSF) runs a parallel, separate process for NSF-funded research through its Office of Inspector General.
    • ORI’s statutory definition of research misconduct — fabrication, falsification, or plagiarism — is the reference definition most other countries cite or adapt.

    United Kingdom: institutions advised by UKRIO

    The UK has no statutory national investigator. Responsibility sits with the employing university or research organisation, which must operate a misconduct procedure consistent with the Concordat to Support Research Integrity (Universities UK, 2019).

    • The UK Research Integrity Office (UKRIO) is an independent charity, not a regulator — it provides advice, a model investigation procedure, and training, but has no statutory power to investigate or sanction.
    • UK Research and Innovation (UKRI), the national funder, requires funded organisations to have robust misconduct procedures as a condition of grant funding, per its Grant Research Practice policy.
    • The newer UK Committee on Research Integrity (UK CORI) monitors sector-wide research integrity but does not investigate individual cases either.
    • Appeals, where permitted, are handled internally by the institution, managed by someone other than the original decision-maker.

    Australia: NHMRC, ARC and the Australian Research Integrity Committee

    Australia operates a shared responsibility model. Institutions investigate under the Australian Code for the Responsible Conduct of Research (2018), jointly issued by the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), and Universities Australia.

    • The Australian Research Integrity Committee (ARIC), a joint NHMRC/ARC initiative, reviews the process an institution followed — not the substance of the misconduct finding — when a complainant or respondent challenges procedural fairness.
    • NHMRC and ARC can withdraw or withhold funding from institutions found not to comply with the Code, giving Australia a funding-conditionality lever similar to the US ORI model.
    • Unlike the US and UK, Australia has an explicit national committee (ARIC) with a formal review remit, though it stops short of full investigative authority — a gap frequently raised in Australian research-integrity policy debate.

    Canada: the Tri-Agency Framework and SRCR

    Canada’s three federal granting agencies — the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) — jointly known as the Tri-Agency, govern misconduct through the Tri-Agency Framework: Responsible Conduct of Research.

    • The Secretariat on Responsible Conduct of Research (SRCR) administers the Framework, advises institutions, and tracks cases, but institutions conduct the actual investigation.
    • Institutions receiving Tri-Agency funds must sign a Memorandum of Understanding agreeing to investigate allegations under the Framework and report outcomes to the SRCR.
    • Consequences for non-compliance can include suspension or termination of Tri-Agency funding to the institution or individual — the same funding-lever mechanism used by ORI and NHMRC/ARC.

    Side-by-side comparison of powers and remit

    The table below summarises where investigative authority actually sits, and what each national body can and cannot do.

    Jurisdiction National body Who investigates National body’s actual power Governing framework
    United States Office of Research Integrity (ORI) Institution Oversight, funding debarment for PHS-funded research 42 CFR Part 93
    United Kingdom UKRIO (advisory charity) Institution Advice, model procedure — no statutory power Concordat to Support Research Integrity (2019)
    Australia ARIC (NHMRC/ARC joint committee) Institution Procedural-fairness review; funding conditionality via NHMRC/ARC Australian Code for the Responsible Conduct of Research (2018)
    Canada SRCR (Tri-Agency Secretariat) Institution Framework administration; funding suspension via Tri-Agency Tri-Agency Framework: Responsible Conduct of Research

    The consistent pattern: every national body relies on funding conditionality — not direct investigative power — as its main enforcement lever. Only the institution has authority to determine the facts of a specific allegation.

    Answer-first Q&A

    Who investigates research misconduct?

    The employing research institution investigates in the US, UK, Australia, and Canada. National bodies such as ORI, UKRIO, ARIC, and the SRCR set standards, provide advice, or review process fairness, but they do not typically conduct the fact-finding themselves — institutional panels of academic peers do.

    Which agencies oversee research misconduct?

    In the US, the Office of Research Integrity and the institution jointly oversee PHS-funded cases. The NSF Office of Inspector General covers NSF grants separately. In the UK, UKRI sets funding conditions while UKRIO advises. In Australia, NHMRC and ARC jointly run ARIC. In Canada, the Tri-Agency (CIHR, NSERC, SSHRC) oversees via the SRCR.

    What counts as research misconduct?

    Research misconduct generally means fabrication, falsification, or plagiarism in proposing, performing, reviewing, or reporting research — the core US federal definition. UKRIO frames it more broadly as behaviours that deliberately or recklessly fall short of expected research standards, distinguishing it from honest error or lesser “questionable research practices.”

    What happens if research misconduct is confirmed?

    Confirmed findings can trigger institutional disciplinary action, correction or retraction of the published record, and notification of funders. National bodies can add consequences: ORI can debar researchers from federal funding; NHMRC/ARC and Canada’s Tri-Agency can suspend or withdraw institutional or individual grant funding.

    What this means for institutions and researchers

    Institutions operating across borders — a common reality for multinational research collaborations — must satisfy multiple, non-equivalent oversight regimes simultaneously. A joint US-UK-Australia project can trigger three separate procedural obligations: 42 CFR Part 93 compliance for PHS funding, Concordat-aligned procedures for UK partners, and Australian Code compliance for NHMRC/ARC-funded co-investigators.

    Research administrators should map which funders and jurisdictions apply before a misconduct concern arises, not after. Confirming institutional procedures satisfy every applicable framework — rather than assuming one national standard covers a whole consortium — reduces the risk of a finding being challenged on procedural grounds in a partner jurisdiction.

    The direction of travel in all four systems is toward tighter funder-driven conditionality rather than new statutory investigative powers: expect national bodies to keep strengthening reporting and audit requirements on institutions, rather than assuming direct investigation duties themselves.

  • UK Research Integrity Office vs US ORI: Comparing Oversight Models

    For institutions with staff, students, or funding on both sides of the Atlantic, understanding how research misconduct is handled is not an academic curiosity — it shapes compliance obligations, reporting duties, and reputational risk. The UK Research Integrity Office (UKRIO) and the US Office of Research Integrity (ORI) are the two most frequently cited reference points for research integrity oversight in the English-speaking research world, yet they sit at opposite ends of the regulatory spectrum: one advisory, one statutory. This analysis sets out what separates the UK’s Concordat-based, self-governing model from the US’s federally regulated assurance regime, and what that gap means in practice for institutions and publishers operating across both jurisdictions.

    Overview: two philosophies of oversight

    The UK has no statutory research-integrity regulator. Instead, oversight is distributed across independent charities, a voluntary sector-wide concordat, and each institution’s own governance. The US, by contrast, ties oversight of biomedical and behavioural research directly to federal funding: any institution receiving Public Health Service (PHS) money — chiefly through the National Institutes of Health (NIH) — must operate under enforceable federal regulation.

    This is the single most important distinction for anyone comparing the two systems: the UK model relies on reputational and contractual incentives to drive good practice, while the US model relies on funding-conditional legal compliance.

    The UK model: UKRIO, the Concordat, and self-governance

    UKRIO was established in 2006 as an independent charity. It offers confidential, impartial advice to researchers, institutions, and members of the public on good research conduct and on handling allegations of misconduct — but it does not investigate cases itself. That responsibility sits with the research organisation where the alleged conduct occurred, guided by UKRIO’s Code of Practice for Research.

    Sitting alongside UKRIO is the Concordat to Support Research Integrity, first published by Universities UK in 2012 and substantially revised in 2019. The Concordat is a voluntary framework, not legislation, built around five commitments:

    • Maintaining the highest standards of rigour and integrity in research
    • Conducting research in an appropriate, ethically sound, and legally compliant way
    • Supporting a research environment that is underpinned by a culture of integrity
    • Using robust and fair processes to investigate allegations of misconduct
    • Working openly and transparently, including public reporting on research integrity

    UK Research and Innovation (UKRI) and Research England are among the Concordat’s signatories, alongside the UK’s major research funders and universities. More recently, UKRI has moved to strengthen system-level coordination through a Committee on Research Integrity, intended to work alongside UKRIO on cross-sector oversight rather than to replace institutional responsibility — a signal that the advisory model is being reinforced rather than converted into a regulator.

    One point that is often glossed over: UKRIO’s Code of Practice defines misconduct more broadly than the classic fabrication-falsification-plagiarism (FFP) triad. It also covers matters such as proceeding without necessary ethical approval, misrepresenting data or authorship, and breaching a researcher’s duty of care — a wider net than the narrower legal definition used in the US.

    The US model: ORI and federal regulatory assurance

    The Office of Research Integrity sits within the US Department of Health and Human Services (HHS), under the Office of the Assistant Secretary for Health. Its jurisdiction is defined by federal regulation — 42 CFR Part 93 — and applies to institutions receiving PHS funding, which includes the large majority of federally funded biomedical and behavioural research in the United States.

    Unlike UKRIO, ORI operates within an assurance framework: institutions receiving PHS funds must file an institutional assurance confirming they have policies and procedures for handling misconduct allegations that meet federal standards. Institutions still conduct the initial investigation, but ORI reviews and can reopen or challenge that process. Where misconduct is confirmed, ORI can recommend administrative actions to HHS, ranging from supervision and certification requirements to debarment from federal funding — a consequence with no direct UK equivalent, since UKRIO has no power to withhold funding from anyone.

    Critically, the federal definition of research misconduct that ORI enforces is narrower than UKRIO’s: fabrication, falsification, and plagiarism (FFP) only, as set out in 42 CFR §93.103. Authorship disputes, data-management failures, or ethics-approval breaches that UKRIO would treat as misconduct concerns typically fall outside ORI’s formal jurisdiction, though they may still be handled under an institution’s own policies.

    Comparing the two models side by side

    Feature UK: UKRIO / Concordat US: Office of Research Integrity
    Legal status Independent charity; voluntary sector concordat Federal agency within HHS
    Established 2006 (UKRIO); 2012, revised 2019 (Concordat) 1992
    Governing basis No statute; reputational/contractual adoption Federal regulation, 42 CFR Part 93
    Investigatory role Advisory only; institutions investigate Reviews/oversees institutional investigations
    Misconduct definition Broader — includes ethics-approval and duty-of-care breaches Narrower — fabrication, falsification, plagiarism only
    Enforcement power None; promotes good practice via guidance Can recommend sanctions, including funding debarment
    Scope All disciplines, all UK research organisations PHS-funded biomedical/behavioural research
    Funding model Subscribing institutions pay for UKRIO’s services Federally funded as part of HHS budget

    Common questions on research integrity oversight

    What is the UK Research Integrity Office?

    The UK Research Integrity Office (UKRIO) is an independent charity, established in 2006, that provides expert advice and guidance on good research practice and the handling of misconduct allegations. It has no statutory or investigatory powers — responsibility for investigating allegations remains with individual research institutions.

    What does the US Office of Research Integrity do?

    The Office of Research Integrity (ORI) is a federal agency within the US Department of Health and Human Services. It oversees research-misconduct policy for Public Health Service-funded research, reviews institutional investigations, and can recommend administrative sanctions, including funding debarment.

    What counts as research misconduct under UKRIO’s Code of Practice?

    UKRIO’s Code of Practice for Research defines misconduct more broadly than fabrication, falsification and plagiarism alone, also covering breaches such as proceeding without ethical approval, misrepresenting data, and failing in a researcher’s duty of care — a wider net than the US federal definition.

    What are the core commitments of the Concordat to Support Research Integrity?

    The Concordat to Support Research Integrity, revised in 2019, sets out five commitments covering rigour and transparency, appropriate governance, a supportive research environment, robust misconduct investigation, and transparent public reporting — voluntarily adopted by UK universities and funders including UKRI.

    Implications for multinational institutions and publishers

    For institutions operating research programmes, joint ventures, or staff exchanges across the UK and US, the practical consequence of these two models is a compliance asymmetry. A collaboration that falls short of UKRIO’s broader Code-of-Practice standard may still be technically compliant with ORI’s narrower FFP definition, and vice versa — an ethics-approval lapse that UKRIO would flag as a misconduct concern may sit outside ORI’s formal jurisdiction entirely.

    • Research administrators managing joint UK-US grants should map both frameworks into a single institutional misconduct policy rather than defaulting to whichever funder’s rules are stricter on paper.
    • Publishers and journal editors handling cross-border authorship disputes should recognise that a “no finding” outcome from a US institution under ORI’s FFP standard does not necessarily mean the same conduct would clear UKRIO’s Code of Practice, or vice versa.
    • Funders operating in both jurisdictions benefit from Concordat-style transparent reporting commitments even where they are not legally required, since it narrows the gap with ORI’s assurance-based accountability.

    Outlook: converging pressures, diverging structures

    Neither system shows signs of formally converging. The UK’s 2019 Concordat revision and UKRI’s growing coordination role reinforce, rather than replace, the advisory model; the US assurance regime remains anchored in federal regulation that would require congressional or HHS rule-making to change materially. What is converging is expectation: international publishers, funders such as Horizon Europe, and bodies like COPE and the Committee on Publication Ethics increasingly expect institutions to demonstrate research-integrity governance regardless of which national model applies. For multinational institutions, the practical answer is not to wait for the UK and US to align, but to build internal policy that satisfies the stricter of the two standards on every point where they diverge.

  • Whose Responsibility Is It to Identify and Report Research Misconduct? UK and US Duties Explained

    Search interest in “whose responsibility is it to identify and report research misconduct” spikes around research-ethics coursework and institutional training, but the confusion it reflects is real and consequential. The honest answer is that whose responsibility it is to identify and report research misconduct depends on the role: the duty is shared, not singular, and it is formalised differently in the UK and the US. Principal investigators, co-authors, supervisors, peer reviewers, editors and institutional officers each hold a piece of the obligation, and neither UK nor US frameworks let any one of these roles opt out.

    This explainer sets out who owes a formal duty to report, which institutional office receives and manages that report, and what legal protection exists for the person who raises the concern.

    Who Carries the Individual Duty to Report?

    The starting point in both UK and US frameworks is that everyone involved in producing, reviewing or supervising research shares a duty of vigilance. A widely cited analysis of collaborative authorship, published in PMC (Helgesson et al., 2017), concludes that “every author shares the responsibility to be attentive to signs of misconduct” and is obliged to act if fraud or fabrication is suspected in a paper they co-author — co-authorship does not dilute individual accountability.

    In practice, the individuals expected to identify and escalate concerns include:

    • Principal investigators (PIs) — responsible for the conduct of their research programme and for acting on concerns raised by team members.
    • Co-authors and collaborators — expected to query irregularities in data, methods or results before a manuscript is submitted or published.
    • Supervisors of doctoral and early-career researchers — responsible for training on research standards and for reporting concerns about supervisees’ conduct.
    • Peer reviewers and journal editors — obliged under Committee on Publication Ethics (COPE) guidance to raise suspected fabrication, falsification or plagiarism (FFP) identified during review, rather than simply rejecting the manuscript.
    • Institutional Review Board / ethics committee members — responsible for flagging non-compliance with approved protocols.

    None of these roles constitutes the sole responsible party. That is the most common misconception behind the search query: there is no single “correct” answer among a multiple-choice list of individuals, because UK and US institutional policy assign the duty collectively.

    Institutional Duty: RIOs, Named Persons and Responsible Officers

    Once an individual raises a concern, formal responsibility shifts to a designated institutional office. The terminology and statutory basis differ between the UK and US, though the underlying model — an initial assessment, followed by a full investigation panel with external academic input — is similar in both systems.

    In the UK, the Concordat to Support Research Integrity (Universities UK, revised 2019) requires every signatory institution to have a published misconduct procedure and to designate a responsible individual — commonly titled the Named Person or Responsible Officer — to receive and triage allegations. UK Research and Innovation’s April 2025 guidance for research organisations goes further, requiring any organisation receiving UKRI funding to investigate allegations of research misconduct involving its staff or students, regardless of who funded the specific project in question. The UK Research Integrity Office (UKRIO) is not a statutory regulator; it is an independent advisory body that publishes a model procedure institutions can adopt or adapt.

    In the US, the equivalent office is the Research Integrity Officer (RIO), a role every institution receiving Public Health Service funding must designate under 42 CFR Part 93. The federal Office of Research Integrity (ORI), within the Department of Health and Human Services, oversees PHS-funded misconduct activity, defines fabrication, falsification and plagiarism (FFP) in federal regulation, and can review institutional findings on appeal.

    Aspect United Kingdom United States
    Sector-wide framework Concordat to Support Research Integrity (Universities UK, rev. 2019) 42 CFR Part 93 (HHS/PHS regulations)
    Designated institutional role Named Person / Responsible Officer Research Integrity Officer (RIO)
    Federal/national oversight body None statutory; UKRIO advises, UKRI mandates investigation for its grantees Office of Research Integrity (ORI), HHS
    Core definition used Fabrication, falsification, plagiarism and other serious deviations from accepted practice Fabrication, falsification, plagiarism (FFP) per 42 CFR §93.103
    Whistle-blower statute Public Interest Disclosure Act 1998 (amends Employment Rights Act 1996) Retaliation protections built into 42 CFR Part 93 institutional assurances

    Common Questions on Reporting Research Misconduct

    Who has the primary responsibility for investigating allegations of research misconduct?

    The host institution holds primary investigative responsibility, not the individual who raises the concern. A designated officer — the Research Integrity Officer in the US or the Named Person in the UK — triages the allegation, and a panel including external academic members conducts the full investigation if warranted.

    Who do you report research misconduct to?

    Concerns should go to the institution’s designated contact — typically the Research Integrity Officer, Named Person, or a supervisor/department head who escalates it formally. Many institutions also run confidential ethics or research-integrity hotlines for concerns raised anonymously.

    Who oversees research misconduct nationally?

    In the US, the Office of Research Integrity oversees PHS-funded misconduct activity on behalf of HHS. In the UK, no single statutory regulator exists; UKRIO provides advisory guidance and a model procedure, while UKRI mandates investigation as a funding condition for its grantees.

    What conduct counts as research misconduct under federal regulations?

    US federal regulation (42 CFR Part 93) defines research misconduct as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting results. Honest error and legitimate differences of scientific opinion are explicitly excluded.

    Whistle-Blower Protections: Reporting Without Retaliation

    Fear of retaliation is the most cited reason researchers stay silent about suspected misconduct, so both jurisdictions build legal protection into the reporting pathway.

    • UK: The Public Interest Disclosure Act 1998, which amends the Employment Rights Act 1996, protects workers who make a “protected disclosure” — including a reasonable belief that a legal obligation, such as a research or funding-body requirement, is being breached — from dismissal or detriment.
    • US: Institutions holding PHS funding must provide, as a condition of their assurance under 42 CFR Part 93, protection for complainants and witnesses against retaliation, and must diligently protect confidentiality where feasible during the assessment and inquiry stages.

    Institutional attribution practices also support accountability once an investigation is under way. Contributor role taxonomies used at submission — such as CRediT, which CASRAI originated in 2014 and which is now stewarded by NISO as ANSI/NISO Z39.104-2022 — make it easier for investigators to establish which named author was responsible for which specific contribution, rather than relying on blanket authorship credit. Research administrators building or reviewing misconduct procedures may find it useful to consult CASRAI’s overview of contributor role taxonomies and the individual CRediT roles alongside broader guidance on authorship standards.

    Implications for Research Administrators and Institutions

    For research administration offices, three practical implications follow from the shared-duty model:

    • Policy visibility matters as much as policy existence. The Concordat requires institutions not just to have a procedure but to publicise it to staff and the public — a written policy that nobody can find fails the spirit of Commitment 4.
    • Reporting channels need redundancy. Because responsibility is distributed across PIs, supervisors, co-authors and reviewers, a single named contact is not enough; institutions typically also need a confidential hotline route and a clear escalation path via department heads.
    • Investigation and disciplinary process must stay separate. UKRIO and ORI guidance both stress that the misconduct investigation determines what happened; any resulting disciplinary action is a distinct, subsequent process, with its own procedural safeguards.

    Institutions that receive UKRI funding should also note that the funder’s own guidance, updated in April 2025, requires investigation of allegations against staff or students as a condition of the funding relationship — independent of whether the specific allegation concerns a UKRI-funded project.

    A Shared, Structured Duty

    There is no single office or job title that owns research misconduct reporting end to end. Individual researchers — PIs, co-authors, supervisors and reviewers — carry a front-line duty to notice and escalate; a designated institutional officer (Research Integrity Officer in the US, Named Person or Responsible Officer in the UK) carries the duty to receive, triage and investigate; and national bodies (ORI in the US; UKRIO advisory guidance and UKRI funding conditions in the UK) set the framework both operate within. As funders sharpen their compliance requirements — UKRI’s April 2025 guidance being the most recent UK example — institutions should expect the expectation of distributed accountability, not a single responsible party, to keep hardening rather than simplifying.

  • Becoming a Research Integrity Officer: Role, Remit and Career Pathway

    As UK universities and research institutes face growing scrutiny over reproducibility, authorship disputes and data fabrication cases, the research integrity officer has moved from a part-time academic add-on to a defined, increasingly professionalised post within research governance teams. For research administrators considering a move into this specialism — or institutions building the role for the first time — the practical questions are consistent: what does the job actually involve, how is it distinct from a research ethics post, and what does it pay.

    What Does a Research Integrity Officer Do?

    A research integrity officer (RIO) is the named individual — sometimes a dedicated post, sometimes a senior academic holding the title alongside other duties — responsible for an institution’s response to concerns about the conduct of research. The remit sits within research governance rather than within a single department, because misconduct allegations can touch grants, publications, supervision and institutional reputation simultaneously.

    Core duties typically include:

    • Managing misconduct allegations — receiving, triaging and, where warranted, formally investigating concerns about fabrication, falsification, plagiarism or other breaches of good research practice.
    • Policy ownership — drafting and maintaining the institution’s research integrity policy and investigation procedures, aligned to the Concordat to Support Research Integrity.
    • Advice and training — briefing researchers, supervisors and postgraduates on responsible research conduct, data management and authorship practice.
    • Horizon-scanning — tracking changes to funder and regulatory requirements and briefing senior leadership on their implications.
    • External liaison — reporting to funders, and in serious cases coordinating with bodies such as UKRIO or equivalent national offices, when an institution’s own procedures require external assurance.

    Unlike a compliance officer, the RIO role is deliberately dual-facing: part investigator, part educator. That combination is what distinguishes it from adjacent research-governance posts and is a recurring theme across UK job descriptions for the role.

    Common Questions About the Role

    What does a research integrity officer do?

    A research integrity officer manages an institution’s response to alleged research misconduct, advises staff and students on good research practice, develops integrity policy, delivers training, and liaises with funders and oversight bodies such as UKRIO or, in the US, the Office of Research Integrity.

    What are the core principles of research integrity?

    In the UK, the Concordat to Support Research Integrity sets out five commitments: honesty, rigour, transparency and open communication, care and respect, and accountability. These underpin institutional policy and RIO casework across the sector.

    What is an integrity officer?

    An integrity officer is a role, not exclusive to research, focused on upholding ethical standards and investigating breaches of conduct within an organisation. In a research setting this narrows to allegations of fabrication, falsification and plagiarism, plus wider good-practice oversight.

    What is the UK Research Integrity Office?

    The UK Research Integrity Office (UKRIO) is an independent charity, not a regulator, that provides confidential advice, training and a Code of Practice for Research to institutions and individuals — it does not employ institutional research integrity officers directly.

    Research Integrity Officer vs Research Ethics Officer

    The two titles are frequently confused, including in job adverts, but the remits are distinct and often sit in separate reporting lines within the same institution.

    Dimension Research Integrity Officer Research Ethics Officer
    Primary focus Conduct of research after it has started — misconduct allegations, data integrity, authorship disputes Approval of research before it starts — participant welfare, consent, risk to human/animal subjects
    Typical trigger A complaint, whistleblower report or funder query about existing work A new study protocol requiring ethical review before data collection
    Governing framework Concordat to Support Research Integrity; institutional misconduct procedure Institutional Research Ethics Committee (REC) terms of reference; Declaration of Helsinki-derived norms
    Reporting relationship Often reports to the Pro-Vice-Chancellor for Research or Registrar Often reports to, or chairs, a Research Ethics Committee
    External counterpart UKRIO (UK); Office of Research Integrity (US); ENRIO members (EU) National/institutional research ethics committee networks

    In practice the two functions overlap at the edges — an ethics breach discovered mid-study can escalate into a misconduct investigation — which is why some smaller institutions combine both under a single research governance lead. Larger research-intensive universities more often separate them into distinct posts.

    Career Pathway and UK Salary Bands

    There is no single accredited qualification that leads directly into the role, which mirrors the position taken by UKRIO and by sector guidance more broadly. Instead, institutions typically recruit against a combination of research background, governance experience and demonstrable case-handling skill. Common entry routes include:

    1. Academic-to-governance move — a PhD-holding researcher moves into research office or governance work, often via a research ethics committee or integrity champion role first.
    2. Research administration progression — an experienced research administrator or grants manager takes on integrity casework as their portfolio grows, then formalises it into a dedicated post.
    3. Legal, compliance or audit background — professionals with investigation, HR-casework or regulatory experience move into research settings, particularly at larger institutions with dedicated Research Governance or Research Integrity offices.
    4. Direct RIO appointment — increasingly common at research-intensive universities, advertised as a standalone senior professional-services post rather than an academic add-on.

    Salary bands vary by institution, grading framework (most UK universities use HERA-derived single pay spines) and whether the post is a stand-alone specialism or combined with wider research governance duties. As an indicative guide only:

    Post level Typical UK context Indicative salary band
    Research Integrity Adviser / Officer Mid-career professional-services role, single institution Broadly £35,000–£48,000
    Senior Research Integrity/Governance Officer Case-handling lead, policy ownership Broadly £48,000–£60,000
    Head of Research Integrity/Governance Strategic lead, reports to senior leadership, larger research-intensive institution Broadly £60,000+

    These bands are indicative only — always verify against the specific institution’s published grading and current job advert, since London weighting, faculty co-funding and combined governance/ethics portfolios all shift the figure materially.

    What This Means for Institutions

    As funders and publishers tighten expectations around data availability, image integrity checks and authorship accuracy, institutions without a clearly defined RIO post risk slower, less consistent responses to misconduct concerns — a reputational and compliance exposure that research administration leadership increasingly treats as a governance priority rather than an academic-freedom afterthought. Clear separation from the research ethics function, rather than folding both into one overstretched role, tends to produce faster case turnaround and clearer audit trails for funders such as UKRI.

    Authorship disputes in particular sit at the intersection of both functions and are a growing share of RIO caseload as contributor-role expectations become more explicit; institutions benefit from RIOs who understand current authorship norms as well as misconduct procedure.

    Outlook: A Professionalising Field

    Expect continued formalisation of the RIO role through the later 2020s: more standalone advertised posts, clearer competency frameworks referencing the Concordat to Support Research Integrity, and closer alignment between UK institutional practice and European counterparts coordinated through ENRIO. For research administrators and early-career researchers weighing a move into this specialism, the practical route in remains consistent — build governance, casework and policy experience, engage with UKRIO’s training resources, and be explicit in applications about the distinction between integrity and ethics remits, since institutions are increasingly hiring for one or the other rather than a blended generalist post.

  • Procedure for the Investigation of Misconduct in Research: A Step-by-Step Committee Guide

    When a university receives a formal allegation of research misconduct, the committee handling it needs a defensible, evidence-based procedure for the investigation of misconduct in research — not an improvised process assembled under pressure. UK institutions have historically anchored their local policies to the UK Research Integrity Office (UKRIO) template procedure, most recently revised in 2023. That document has now been sunset: UKRIO published a replacement, the Detailed Procedure for Investigating Breaches of Research Integrity, in December 2025, alongside long-standing US practice codified by the Office of Research Integrity (ORI). This guide synthesises both models into one practical procedure — covering intake, inquiry, formal investigation and reporting — that institutional committees can apply directly.

    What Counts as Research Misconduct

    Most frameworks converge on a common core: fabrication, falsification and plagiarism (FFP). ORI applies this narrow FFP definition when it proposes federal findings against researchers funded by the US Public Health Service. UK practice, shaped by the Concordat to Support Research Integrity (Universities UK), is broader.

    UK institutional policies typically also capture:

    • Mismanagement of conflicts of interest that were not properly declared
    • Breach of duty of care to research participants, patients or animals
    • Misrepresentation of involvement, including ghost or guest authorship
    • Improper handling of a misconduct allegation itself, including victimising a whistleblower

    Committees should confirm which definition their institutional policy uses before opening a case. Scope decisions made at intake determine whether a matter proceeds as misconduct, as poor research practice, or as a contributorship dispute better resolved through clearer role attribution.

    The Procedure at a Glance: Four Phases from Intake to Report

    Institutional procedures differ in their exact labels but converge on the same underlying logic. The table below maps UKRIO terminology against the ORI model used across US federally funded research.

    Generic phase UKRIO term ORI (US) term Core purpose
    1. Intake Receipt of Allegations Allegation Log the complaint and confirm it falls within scope and jurisdiction
    2. Screening Assessment Inquiry Establish whether there is a prima facie case warranting full investigation
    3. Formal investigation Investigation Investigation Panel-led evidentiary examination, typically with an external member
    4. Outcome Outcome / Report Investigation Report / adjudication Findings, sanctions and correction of the research record
    5. Appeal Appeal (institution-specific) Institutional and federal oversight review Review of process fairness and proportionality of any sanction

    Step-by-Step: Running Each Phase

    The sequence below reflects UKRIO’s revised phase structure and ORI’s assessment-inquiry-investigation model, condensed into a working checklist committees can follow.

    Phase 1: Intake and Initial Screening

    The designated Research Integrity Officer or Named Person logs the allegation in writing, confirms it concerns research conducted under the institution’s auspices, and checks it is not vexatious, out of time, or already covered by another process such as a student misconduct or HR grievance procedure. Both the respondent and complainant are typically notified that a review has opened.

    Phase 2: The Inquiry (Preliminary Assessment)

    A small screening panel gathers initial evidence — underlying data, correspondence, relevant publications — to decide whether a prima facie case exists. This is a fact-finding exercise, not a determination of guilt. Many cases close here because the conduct reflects honest error or a legitimate difference of scientific opinion rather than misconduct.

    Phase 3: The Formal Investigation

    If the inquiry finds sufficient grounds, a Formal Investigation Panel is convened, usually including at least one member external to the institution. The panel interviews the complainant, respondent and witnesses, scrutinises data and lab records, and applies the balance-of-probabilities standard used across UK and most US institutional procedures.

    Phase 4: Outcome, Reporting and Correcting the Record

    The panel issues a written report: allegations upheld, partially upheld, or not upheld. Where misconduct is confirmed, action can include disciplinary sanctions, retraction or correction of affected publications, and notification of co-authors, journals, funders and, where relevant, professional or regulatory bodies.

    Phase 5: Appeal

    Most institutions allow an appeal limited to procedural irregularity, new evidence, or disproportionate sanction, heard by a senior figure with no prior involvement in the case. The appeal outcome is normally final at institutional level, though funders such as UKRI may separately review an institution’s handling of a case tied to their funding.

    Answer-First: Committee FAQs

    What are the phases of a research misconduct allegation?

    Most procedures run through four to five phases: intake (logging and scoping the allegation), inquiry or assessment (checking for a prima facie case), formal investigation (panel-led evidence review), and outcome and reporting, followed by an optional appeal stage.

    What is the first phase in response to a research misconduct allegation?

    The first phase is intake, sometimes called Receipt of Allegations. A designated Research Integrity Officer logs the complaint in writing, confirms it falls within the institution’s jurisdiction and definition of misconduct, and notifies the respondent before any evidence review begins.

    Who investigates allegations of research misconduct?

    The employing or funding institution investigates in the first instance, usually through a Formal Investigation Panel including an external member. Bodies such as UKRIO and ORI provide advice and procedural frameworks but do not typically run individual case investigations themselves.

    Whose responsibility is it to identify and report research misconduct?

    Reporting is a shared duty. Principal investigators, co-authors, reviewers, students and professional staff must raise good-faith concerns, usually to a named Research Integrity Officer. Institutional policies typically protect whistleblowers from retaliation once a concern is raised honestly.

    Roles, Prevention and Governance Implications

    Investigation procedures are remedial — they respond after harm has occurred. Prevention is cheaper and protects institutional reputation long before a case reaches a panel. Evidence-based measures include mandatory research integrity training at induction and supervision milestones, data management plans reviewed at project setup, and clear contributor-role disclosure on every output.

    Authorship disputes are a recurring trigger for misconduct allegations. Transparent attribution of who did what — using a structured framework such as the CRediT contributor role taxonomy, which CASRAI originated in 2014 and which is now stewarded by NISO as ANSI/NISO Z39.104-2022 — reduces the ambiguity that often escalates into a formal complaint. Institutions embedding role transparency into their research administration workflows give committees clearer evidence to work with if a dispute does arise.

    The governance stakes are rising. UKRI’s April 2025 guidance for research organisations ties funder confidence directly to the robustness of an institution’s misconduct procedure, and poorly documented cases increasingly surface in funder audits and, where publications are affected, in retraction and correction notices tracked by services such as Retraction Watch. Committees that document each phase properly do more than defend individual decisions on appeal — they protect the institution’s standing with funders and publishers.

    Looking ahead, expect UKRIO’s December 2025 Detailed Procedure and equivalent US federal guidance to keep converging on shared definitions, external panel membership and proportionate, documented outcomes. Institutions that update their local policy to reference the current UKRIO and ORI models now, rather than after their next case, will be better placed to run a fair, defensible investigation when an allegation lands.

  • Scotland’s New Research Integrity Policy: What UK Institutions Must Do Before September 2026

    The Scottish Funding Council (SFC) approved a new research integrity policy in May 2026, and it takes effect on 1 September 2026 for every Scottish higher education institution that receives SFC research and innovation funding. The policy is not a rewrite of institutional codes of conduct — those remain the responsibility of individual universities — but it introduces a mandatory reporting relationship between institutions and their funder that did not previously exist in Scotland, and it gives research offices a firm compliance deadline to work against.

    For pre-award, governance and research integrity teams, the practical question is not whether the policy is welcome — it broadly restates principles already embedded in the UK-wide Concordat to Support Research Integrity — but what operational changes are needed before the start date, and how Scotland’s approach compares with the mechanisms already in place across the rest of the UK.

    What the Scottish Funding Council’s new policy requires

    The SFC policy defines research integrity in terms consistent with UK Research and Innovation’s (UKRI) own framing: research that is trustworthy, ethical and responsible, guided by five principles — honesty, rigour, transparency and open communication, care and respect, and accountability. Those five principles mirror the commitments set out in the revised Concordat to Support Research Integrity, so institutions already aligned with the Concordat are not starting from zero.

    The operative change is procedural. Under the new policy, institutions receiving SFC research and innovation funding must notify the Council of the outcome of any formal investigation into research misconduct, with a benchmark turnaround of no more than one month following the investigation’s conclusion. This is a step beyond the general expectation, long established through the Concordat, that funded organisations simply maintain “appropriate structures, policies and procedures” to support integrity — it creates a specific, time-bound reporting obligation tied to SFC funding.

    Three scope points matter for compliance planning:

    • The policy applies to Scottish higher education institutions that receive SFC research and innovation funding, and to research activity the Council funds directly.
    • The SFC will not act as an appeals body for individual misconduct cases, will not support individuals through investigations, and will not grant ethical clearance for research projects — those functions stay with the institution and, where applicable, research ethics committees.
    • The Council reserves the right to act where misconduct is reported, which may include action relating to individuals or a review of an institution’s own processes and systems — a lever that raises the stakes of a weak or slow internal investigation process.

    How it fits the UK-wide Concordat to Support Research Integrity

    The Scottish policy is explicitly framed as complementary to, not a replacement for, the Concordat to Support Research Integrity — the UK-wide framework signed by universities, funders and sector bodies and refreshed in April 2025. The revised Concordat broadened its recognition of contributors to research beyond principal investigators to include research-enabling staff such as technicians, data managers and research development professionals, and it updated its language on questionable research practices.

    The UK Research Integrity Office (UKRIO) updated its own UKRIO Code of Practice for Research to Version 3.5 in July 2025 specifically to align with the revised Concordat, adding new guidance on the responsible use of AI and other emerging technologies in research, and deliberately softening language around misconduct procedures to reduce the stigma that UKRIO’s own 2024 research found was discouraging staff from reporting concerns. Scotland’s new policy sits on top of this existing architecture: it does not change what “good research conduct” means, but it changes who has to be told when conduct falls short, and how quickly.

    Scotland versus the rest of the UK: a comparison

    No other UK funding council currently mandates misconduct-outcome reporting on the same timetable as the SFC. The table below sets out how the main frameworks compare for a Scottish, UK-wide and cross-border institution.

    Framework Scope Misconduct reporting to funder Status from September 2026
    SFC Research Integrity Policy Scottish HEIs receiving SFC research/innovation funding Mandatory outcome notification, benchmark of one month post-conclusion Mandatory, funding-linked
    Concordat to Support Research Integrity (2025) UK-wide, all signatory institutions and funders General expectation of appropriate structures and annual statements; no fixed reporting clock Voluntary sector commitment
    UKRI Guidance on Investigation of Research Misconduct Organisations holding UKRI grants, UK-wide Requires investigation of allegations against funded staff/students; reporting terms set out in grant conditions Grant-condition based
    UKRIO Code of Practice for Research (v3.5) Any UK or international research organisation, adoptable in full or in part No reporting mandate; benchmark and advisory framework only Voluntary adoption

    The practical effect for cross-border institutions — a Scottish university with UKRI grants, for example, or a UK-wide research group with a Scottish node — is that the SFC clock now runs in parallel with, not instead of, existing UKRI grant conditions and Concordat commitments. Research offices need a single misconduct-tracking process that can satisfy the tightest of the applicable deadlines, rather than separate parallel logs.

    What pre-award and research offices must change before September 2026

    With roughly two months between SFC approval and the effective date, research integrity and governance teams have a narrow window to close gaps. The priority actions are:

    • Map the reporting chain. Confirm who in the institution is authorised to notify the SFC of an investigation outcome, and build the one-month clock into the misconduct investigation procedure itself, not as an afterthought once a case closes.
    • Audit investigation timelines. If current misconduct procedures routinely run beyond a month from conclusion to formal sign-off, the reporting deadline effectively compresses the institution’s own internal process.
    • Update the annual statement on research integrity. Institutions already produce a Concordat-aligned annual statement; this is the natural place to reference the new SFC notification duty and evidence compliance.
    • Brief research ethics committees and REI managers. The SFC has been explicit that it will not adjudicate individual cases or grant ethical approval, so institutions cannot rely on the Council to absorb any of that governance load.
    • Cross-check against UKRI and other funder conditions. Where a case involves UKRI or other funding alongside SFC money, confirm which reporting obligation applies first and ensure both are met.

    Questions institutions are asking

    What is a research integrity policy?

    A research integrity policy is an institutional or funder document setting out the standards of honesty, rigour, transparency, care and accountability expected in research, alongside the roles, training and procedures — including misconduct investigation — that put those standards into practice across the research lifecycle.

    What is the Concordat to Support Research Integrity?

    The Concordat to Support Research Integrity is a UK-wide sector agreement, signed by universities, funders and representative bodies, committing signatories to five shared responsibilities for maintaining rigour, transparency and accountability in research, most recently revised in April 2025.

    Who investigates research misconduct in the UK?

    Individual institutions investigate research misconduct allegations under their own procedures, informed by the UKRIO Code of Practice for Research; funders such as UKRI and, from September 2026, the SFC in Scotland, set reporting conditions but do not conduct the investigations themselves.

    What happens if an institution breaches its research integrity policy?

    Consequences depend on the framework: internally, breaches can trigger disciplinary action up to dismissal; externally, funders including the SFC can review an institution’s processes and systems, and in serious cases reconsider its funding relationship, though the SFC has stated it will not act as an appeals body.

    Implications beyond Scotland

    Scotland’s move is likely to be watched closely by the other UK nations’ funding bodies as a test case for whether time-bound, funder-mandated misconduct reporting improves transparency without overwhelming research offices. For institutions operating research programmes across borders — a common pattern for Russell Group and consortium-led projects — the immediate implication is administrative: misconduct-case tracking systems built around a single national timetable now need to accommodate a jurisdiction-specific clock for any Scottish-funded strand of work.

    There is also a signalling effect for research culture more broadly. Mandatory outcome reporting, even where the funder is explicit that it will not re-adjudicate cases, tends to raise the internal profile of misconduct procedures and can influence how quickly institutions resource investigation teams. Given UKRIO’s own 2024 finding that fear of stigma was a barrier to reporting concerns, institutions would do well to pair procedural compliance with the destigmatising language changes UKRIO built into Version 3.5 of its Code, rather than treating the SFC deadline as a purely administrative exercise.

    What to watch next

    Three things are worth tracking as the September 2026 start date approaches: whether the SFC publishes supporting guidance or a template notification form ahead of the deadline; whether other UK funders signal an intention to introduce comparable time-bound reporting; and how the first wave of notified outcomes, likely to surface in aggregate through SFC or Universities Scotland reporting during 2027, shapes the sector’s view of whether mandatory reporting changes behaviour or simply changes paperwork. Research offices that treat the current window as a chance to audit and tighten investigation timelines — rather than a compliance box to tick in August — will be best placed regardless of how the policy evolves.